Paragon 28, Inc. (FNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 14445 GRASSLANDS DRIVE
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments56,74785,88338,46856,32573,00293,647
Cash and cash equivalents56,74785,88338,46856,32573,00293,647
Receivables35,20137,85838,30236,66533,25828,275
Inventory, net of allowances, customer advances and progress billings85,22569,17460,94854,77151,70043,185
Inventory85,22569,17460,94854,77151,70043,185
Other current assets3,2574,1674,6581,9473,1293,448
Total current assets:180,430197,082142,376149,708161,089168,555
Noncurrent Assets
Operating lease, right-of-use asset   1,795   
Property, plant and equipment70,93666,81061,93858,59156,06651,850
Intangible assets, net (including goodwill)47,38647,60247,85247,82547,32748,022
Goodwill25,46525,46525,46526,97526,97526,672
Intangible assets, net (excluding goodwill)21,92122,13722,38720,85020,35221,350
Deferred income tax assets319354148841563303
Other undisclosed noncurrent assets1,7661,697    
Total noncurrent assets:120,407116,463111,733107,257103,956100,175
TOTAL ASSETS:300,837313,545254,109256,965265,045268,730
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities54,07145,98441,74633,98336,27630,196
Taxes payable497305492
Accounts payable29,68120,53814,93913,97914,56411,877
Accrued liabilities24,39025,44626,80719,50721,40717,827
Debt652690728735757781
Business combination, contingent consideration, liability  3,4603,386   
Other liabilities1,7003,7723,8446,8896,9267,433
Other undisclosed current liabilities 209,74818,798   
Total current liabilities:56,44363,65468,50241,60743,95938,410
Noncurrent Liabilities
Long-term debt and lease obligation42,25942,20442,18242,49242,51942,471
Long-term debt, excluding current maturities42,25942,20442,18242,49242,51942,471
Liabilities, other than long-term debt3,0972,5352,4971,4931,6293,347
Accounts payable and accrued liabilities635635527527527527
Deferred income tax liabilities62037734259197302
Other liabilities1,8421,5231,6289079052,518
Total noncurrent liabilities:45,35644,73944,67943,98544,14845,818
Total liabilities:101,799108,393113,18185,59288,10784,228
Equity
Equity, attributable to parent199,038205,152140,928171,373176,938184,502
Common stock824821776769764763
Treasury stock, value(5,982)(5,982)(5,982)(5,982)(5,982)(5,982)
Additional paid in capital292,350287,286213,956207,109202,367199,736
Accumulated other comprehensive loss(415)(132)(33)(1,497)(909)(316)
Accumulated deficit(87,739)(76,841)(67,789)(29,026)(19,302)(9,699)
Total equity:199,038205,152140,928171,373176,938184,502
TOTAL LIABILITIES AND EQUITY:300,837313,545254,109256,965265,045268,730

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues51,00952,03651,50846,00642,49841,371
Cost of revenue(8,858)(8,906)(9,537)(8,491)(7,638)(6,791)
Gross profit:42,15143,13041,97137,51534,86034,580
Operating expenses(51,510)(50,869)(78,016)(46,004)(43,938)(43,015)
Operating loss:(9,359)(7,739)(36,045)(8,489)(9,078)(8,435)
Nonoperating income (expense)(1,270)(1,384)(3,088)(1,034)(452)(769)
Other nonoperating income (expense)(467)(179)(1,824)59652(101)
Interest and debt expense(803)(1,205)(1,264)(1,093)(1,104)(668)
Loss from continuing operations before equity method investments, income taxes:(11,432)(10,328)(40,397)(10,616)(10,634)(9,872)
Other undisclosed income from continuing operations before income taxes8031,2051,2641,0931,104668
Loss from continuing operations before income taxes:(10,629)(9,123)(39,133)(9,523)(9,530)(9,204)
Income tax expense (benefit)(269)71370(201)(73)(32)
Loss from continuing operations:(10,898)(9,052)(38,763)(9,724)(9,603)(9,236)
Loss before gain (loss) on sale of properties:(9,724)(9,603)(9,236)
Net loss available to common stockholders, diluted:(10,898)(9,052)(38,763)(9,724)(9,603)(9,236)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(10,898)(9,052)(38,763)(9,724)(9,603)(9,236)
Comprehensive loss:(10,898)(9,052)(38,763)(9,724)(9,603)(9,236)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(283)(99)1,464(588)(593)(324)
Comprehensive loss, net of tax, attributable to parent:(11,181)(9,151)(37,299)(10,312)(10,196)(9,560)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: